Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 336 clinical trials
featured
  • 560 views
  • 23 Nov, 2020
  • 12 locations
featured
  • 72 views
  • 14 Dec, 2020
  • 21 locations
featured
A safety and Tolerability Study of INCB053915 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma

The purpose of this study is to evaluate the safety and tolerability of INCB053914 in combination with INCB050465 in relapsed or refractory Diffuse Large B-Cell Lymphoma (DLBCL).  

lymphomas
lymphoma
b-cell lymphoma
  • 45 views
  • 14 Dec, 2020
  • 5 locations
featured
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas

This study is being done to evaluate the safety, tolerability and effectiveness of Oral CG-806 for the treatment of patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma

lymphoma
chronic lymphocytic leukemia
  • 28 views
  • 23 Jan, 2020
  • 14 locations
A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)

The objective of this study are to evaluate the safety and tolerability of ABT-199 (venetoclax) in patients with advanced Cutaneous T cell lymphoma (CTCL). A secondary objective is to explore

treatment regimen
platelet count
bexarotene
romidepsin
electron beam therapy
  • 3 views
  • 29 Jan, 2021
  • 1 location
Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor Copanlisib Given in Combination With the Immunotherapeutic Agents Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Patients with relapsed or refractory follicular or marginal zone lymphoma who have received at least one prior line of therapy will receive Copanlisib IV: day 1, 8, 15 every 28

  • 0 views
  • 27 Jan, 2021
  • 2 locations
Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

To study the safety and effectiveness of HLA haploidentical CAR-NK cells targeting CD19 in patients with B-cell non-Hodgkin's lymphoma

cell therapy
anthracyclines
monoclonal antibodies
diffuse large b-cell lymphoma
large b-cell lymphoma
  • 0 views
  • 24 May, 2021
  • 1 location
Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma

This is an open-label, multicenter, dose-escalation phase 1 study to determine the Safety and Efficacy of BZ019 in relapsed or refractory CD19+ B-cell Lymphoma subjects.

  • 0 views
  • 23 Jan, 2021
  • 2 locations
Zanubrutinib in Combination With Lenalidomide With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

The primary objective of this study is to determine the maximum tolerated doses (MTD) and the recommended Phase 2 dose (RP2D), and safety and tolerability of zanubrutinib in combination with lenalidomide, with or without rituximab in participants with R/R DLBCL by dose escalating lenalidomide

  • 0 views
  • 26 Jan, 2021
  • 4 locations
  • 0 views
  • 05 Feb, 2021
  • 1 location